ALEMG — Laboratoires Euromedis SA Cashflow Statement
0.000.00%
Last trade - 00:00- €11.18m
- €4.02m
- €36.22m
- 42
- 64
- 47
- 48
Annual cashflow statement for Laboratoires Euromedis SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | — | — |
| Source: | ARS | ARS | ARS | ||
| Standards: | FAS | FAS | FAS | — | — |
| Status: | Final | Final | Final | fx Preliminary | fx Preliminary |
| Net Income/Starting Line | 22.9 | 2.31 | -5.94 | — | — |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 0.193 | 1.24 | 0.009 | — | — |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -15.5 | 15.7 | 3.89 | — | — |
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 13.5 | 19.2 | -1.05 | — | — |
| Capital Expenditures | -0.66 | -1.84 | -1.03 | — | — |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0.068 | 0.707 | -0.038 | — | — |
| Sale of Fixed Assets | |||||
| Change in Net Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.592 | -1.13 | -1.07 | — | — |
| Financing Cash Flow Items | 0.03 | 0.03 | 0.03 | — | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 9.29 | -1.25 | -2.4 | — | — |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 22.2 | 16.9 | -4.52 | — | — |